Skip to main content
. 2021 Sep 23;48(1):80–89. doi: 10.1093/schbul/sbab111

Table 1.

Clinical and Demographic Information Comparing SZ to HCs

Variable HC (n = 21) SZ (n = 26, SZ = 18, SZA = 8) Test Stat (χ2, F) P
Age (years) 38.0 (11.6) 37.0 (12.7) 0.07 .79
Sex (female/male) 7/14 6/20 0.21 .65
Race (AA/CA/OT) 2/15/04 9/13/04 4.11 .13
Visual acuity 0.92 (0.24) 0.83 (0.28) 1.54 .22
BMI 26.3 (4.0) 30.5 (8.0) 4.76 .034*
Systolic blood pressure 122.2 (10.0) 124.0 (14.5) 0.20 .65
Diastolic blood pressure 77.4 (10.4) 76.4 (13.4) 0.08 .78
Cardiometabolic disorder (yes/no) 6/14 7/19 0.05 .82
Smoking status (yes/no) 0/20 8/18 8.5 .006**
Duration of illness (months) 163.6 (153.1)
Antipsychotic status (yes/no) 22/3
CPZ equivalents 338.8 (256.3)
Social Functioning Scale 153.3 (17.0) 127.5 (19.6) 22.0 <.001***
Global Assessment of Functioning 81.9 (9.4) 46.2 (15.5) 82.2 <.001***
BACS composite score −0.16 (0.73) −0.69 (0.77) 5.19 .028*
PANSS total score 55.5 (14.6)
PANSS positive symptoms score 13.2 (4.7)
PANSS negative symptoms score 13.7 (4.8)
Young Mania Rating Scale 7.0 (6.5)

Note: HC = healthy control; SZ = schizophrenia; SZA = schizoaffective disorder; AA = African American; CA = Caucasian; OT = other; BMI = body mass index; CPZ = chlorpromazine; BACS = Brief Assessment of Cognition in Schizophrenia; PANSS = Positive and Negative Syndrome Scale . Continuous data are given as mean (SD). Cardiometabolic disease variable accounts for whether person had either a cardiovascular (heart or vessels) or metabolic disorder. Smoking variable accounts for whether a person had smoked within the last 30 d.

Significant test statistics are in bold and denoted as *P < .05, **P < .01, and ***P < .005.